HCmed Innovations is a leading brand that provides a comprehensive drug-device combination platform built on its core product portfolio of vibrating mesh nebulizers. Their mission is to create highly integrated drug-device combination products for affordable-best-quality, specifically focusing on nebulization of high-value therapeutic drugs. These drugs can include small molecule synthetics, large molecule biologics, solutions, suspensions, and even difficult-to-deliver high viscosity drugs.

To achieve optimal aerosol performance for diverse formulations, HCmed works closely with partners to tailor the components and parameters of their mesh technology. With the strength of Taiwan's world-class manufacturing industry and a well-established GMP certified manufacturing facility, their products have received approval from multiple health authorities and have been successfully launched in selected regions. HCmed's vision is centered on bringing significant value to global pharma partners by designing cost-efficient and risk-minimized combination products that make great contributions in the respiratory field